KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- One in 6 Parents in US Delay or Skip Routine Vaccination for Children September 15, 2025However, a large majority of parents in the US believe routine childhood vaccines, such as the measles, mumps, and rubella vaccine and polio vaccine, are safe and important.
- Adverse Events Prominent During Post-Pneumococcal Vaccination September 15, 2025Using the vaccine adverse event reporting system database, researchers address adverse events following pneumococcal vaccination as well as the association between adverse events and vaccine administration.
- Capvaxive Shows Immune Responses to All 21 Serotypes for Children, Adolescents September 15, 2025Merck’s pneumococcal 21-valent conjugate vaccine was noninferior to the pneumococcal 23-valent polysaccharide vaccine for all 12 shared serotypes and superior to 9 unique serotypes.
- Q&A: Pharmacists Guide Patients Through Clinical, Social Determinants of Nonadherence September 15, 2025Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, discusses the ongoing issue of medication nonadherence and the pharmacists’ crucial role in managing it.
- Inadequate Contraceptive Information Hinders Equity in Reproductive Care September 14, 2025Researchers aim to understand patients’ perception of whether or not they have sufficient information on contraceptives.
- Pharmacists Emerge as Key Educators in Women's Health, Destigmatizing Menstrual Pain September 13, 2025Explore effective strategies for managing menstrual pain, including diet, exercise, and nonpharmacological therapies, while embracing women's health awareness.
- Pharmacist Discusses Top OTC Strategies for Managing Menstrual Pain September 12, 2025Joanna Lewis, PharmD, MBA explores effective over-the-counter solutions for menstrual cramps, including NSAIDs, supplements, and tips for optimal relief.
- Community Pharmacists: Bridging Health Care Gaps and Expanding Patient Access September 12, 2025Community pharmacists are increasingly playing a vital role in expanding health care access by offering clinical services like chronic disease management, HIV prevention, and reproductive health care.
- Patients Must Seek Pharmacists, Other Providers For Reproductive Health as Abortion Clinics Close September 12, 2025Abortion clinic closures impact reproductive health access, prompting a shift towards pharmacists for contraceptive care and highlighting urgent public health needs.
- Pharmacy Industry Leaders Gather to Discuss Most Favored Nation Drug Policy September 12, 2025The panel discussion features pharmacy leaders, policy experts, and well-known legal minds discussing the Most Favored Nation drug policy and its overarching implications.
Pharmacy Times articles
- Op-Ed: Vaccine Policy Changes Are Undoing Pharmacy Access September 15, 2025Pharmacists face challenges as recent federal policy changes threaten their expanded roles in vaccination and public health, impacting patient access to care.
- World Lymphoma Awareness Day Highlights Innovation in Patient Care September 15, 2025World Lymphoma Day highlights the rising prevalence of lymphoma and innovative treatments, emphasizing the role of pharmacists in patient care.
- Study Finds Overweight Status May Aid Older Adults in Surgery Recovery September 15, 2025Research reveals that this population may experience lower short-term mortality rates after major surgery, challenging traditional BMI guidelines.
- Adults With Celiac Disease Often Undervaccinated Against Pneumococcal Disease September 15, 2025Use of educational resources at a gastrointestinal office improved pneumococcal vaccine uptake in patients with celiac disease.
- Optimizing Immunization Efforts During Respiratory Virus Season September 15, 2025Crystal Hodge, PharmD, BCIDP, BCPS, discusses a 3-pronged approach—isolating, vaccinating, and educating—to help pharmacists manage respiratory virus season and routine immunizations like MMR.
- Tarlatamab Combination Regimen Demonstrates Potential as Maintenance Therapy in ES-SCLC September 15, 2025When combined with an anti–PD-L1 therapy, tarlatamab significantly improves overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC).
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research September 15, 2025Abdulwhab Shremo Msdi, PharmD, BCIDP, advances research in infectious diseases and microbiome-related conditions.
- Pharmacy Policy Updates for September 2025 September 15, 2025Explore insights into ongoing tensions in the pharmacy industry and their potential impact on competition.
- FDA Cracks Down on Deceptive Prescription Drug Advertising September 15, 2025New FDA regulations are intended to enhance transparency in prescription drug advertising, empowering pharmacists to educate patients on medication risks and benefits.
- Semaglutide Could Offer Potential Treatment for Cocaine Use Disorder September 14, 2025Research reveals semaglutide's potential to reduce cocaine-seeking behavior in rats, suggesting a promising avenue for treating cocaine dependency in humans.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com